Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 4534

1.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
2.

Social phobia: a pharmacologic treatment overview.

Jefferson JW.

J Clin Psychiatry. 1995;56 Suppl 5:18-24. Review.

PMID:
7782272
3.

WCA recommendations for the long-term treatment of social phobia.

Van Ameringen M, Allgulander C, Bandelow B, Greist JH, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP; World Council of Anxiety.

CNS Spectr. 2003 Aug;8(8 Suppl 1):40-52. Review.

PMID:
14767397
4.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
5.

The pharmacotherapy of social phobia.

Pollack MH, Gould RA.

Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:71-5. Review.

PMID:
8923113
6.

Drugs in development for social anxiety disorder: more to social anxiety than meets the SSRI.

van Ameringen M, Mancini C, Farvolden P, Oakman J.

Expert Opin Investig Drugs. 2000 Oct;9(10):2215-31. Review.

PMID:
11060802
7.

The treatment of childhood social anxiety disorder.

Beidel DC, Ferrell C, Alfano CA, Yeganeh R.

Psychiatr Clin North Am. 2001 Dec;24(4):831-46. Review.

PMID:
11723636
8.

Moclobemide: therapeutic use and clinical studies.

Bonnet U.

CNS Drug Rev. 2003 Spring;9(1):97-140. Review.

9.

Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment.

Brunello N, den Boer JA, Judd LL, Kasper S, Kelsey JE, Lader M, Lecrubier Y, Lepine JP, Lydiard RB, Mendlewicz J, Montgomery SA, Racagni G, Stein MB, Wittchen HU.

J Affect Disord. 2000 Oct;60(1):61-74. Review.

PMID:
10940449
10.

[Psychiatric and psychological aspects of premenstrual syndrome].

Limosin F, Ades J.

Encephale. 2001 Nov-Dec;27(6):501-8. Review. French.

PMID:
11865558
11.

Social phobia: everyone's disorder?

Jefferson JW.

J Clin Psychiatry. 1996;57 Suppl 6:28-32. Review.

PMID:
8647795
12.

New uses for antidepressants: social phobia.

Keck PE Jr, McElroy SL.

J Clin Psychiatry. 1997;58 Suppl 14:32-6; discussion 37-8. Review.

PMID:
9418744
13.

Recent advances in the psychopharmacology of social phobia.

Den Boer JA, Van Vliet IM, Westenberg HG.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Jul;18(4):625-45. Review.

PMID:
7938556
14.

Pharmacotherapy of social anxiety disorder.

Blanco C, Antia SX, Liebowitz MR.

Biol Psychiatry. 2002 Jan 1;51(1):109-20. Review.

PMID:
11801236
15.

Treatment of social phobia with antidepressants.

Schneier FR.

J Clin Psychiatry. 2001;62 Suppl 1:43-8; discussion 49. Review.

16.

Medication therapy for social phobia.

Marshall RD, Schneier FR, Fallon BA, Feerick J, Liebowitz MR.

J Clin Psychiatry. 1994 Jun;55 Suppl:33-7. Review.

PMID:
8077172
17.

Social anxiety disorder: designing a pharmacologic treatment strategy.

Pollack MH.

J Clin Psychiatry. 1999;60 Suppl 9:20-6.

18.

Brain function in social anxiety disorder.

Argyropoulos SV, Bell CJ, Nutt DJ.

Psychiatr Clin North Am. 2001 Dec;24(4):707-22. Review.

PMID:
11723629
19.

Pharmacotherapy of social anxiety disorder: what does the evidence tell us?

Davidson JR.

J Clin Psychiatry. 2006;67 Suppl 12:20-6. Review.

20.

[Interest of the use of pindolol in the treatment of depression: review].

Brousse G, Schmitt A, Chereau I, Eschalier A, Dubray C, Llorca PM.

Encephale. 2003 Jul-Aug;29(4 Pt 1):338-50. Review. French.

PMID:
14615704

Supplemental Content

Support Center